Central Lab Services Market Size, Share & Industry Analysis By Service Type (Safety Testing, Biomarker Testing, Genetic Testing, Immunology Testing, Anatomic Pathology & Histology, Microbiology & Infectious Disease Testing, Bioanalytical Testing, & Others), By Phase (Phase I, Phase II, Phase III, & Phase IV), By Modality (Small Molecules, Biologics, Medical Devices, & Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology, & Others), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, CROs, & Others), and Regional Forecast, 2026-2034

Last Updated: June 24, 2026 | Format: PDF | Report ID: FBI107163

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 6.5% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Service Type, Phase, Modality, Therapeutic Area, End User, and Region
By Service Type	Safety Testing Biomarker Testing Genetic Testing Immunology Testing Anatomic Pathology & Histology Microbiology & Infectious Disease Testing Bioanalytical Testing Others
By Phase	Phase I Phase II Phase III Phase IV
By Modality	Small Molecules Biologics Medical Devices Others
By Therapeutic Area	Oncology Infectious Diseases Neurology Cardiology Others
By End User	Pharmaceutical & Biotechnological Companies Medical Device Companies CROs Others
By Region	North America (By Service Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country) U.S. (By Phase) Canada (By Phase) Europe (By Service Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region) U.K. (By Phase) Germany (By Phase) France (By Phase) Italy (By Phase) Spain (By Phase) Scandinavia (By Phase) Rest of Europe (By Phase) Asia Pacific (By Service Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region) China (By Phase) Japan (By Phase) India (By Phase) Australia (By Phase) Southeast Asia (By Phase) Rest of Asia Pacific (By Phase) Latin America (By Service Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region) Brazil (By Phase) Mexico (By Phase) Rest of Latin America (By Phase) Middle East & Africa (By Service Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region) GCC (By Phase) South Africa (By Phase) Rest of the Middle East & Africa (By Phase)